Ovarian Cancer News & Features
ORLANDO, FL—Effective nursing interventions for the cluster of sleep disturbance, pain, anxiety, depression, and low energy/fatigue (SPADE) symptoms women with ovarian cancer report secondary to ongoing chemotherapy treatment are limited, concludes a literature review presented at the ONS 40th Annual Congress.
Oral contraceptive use, tubal sterilization, and genetic testing and counseling recommended by the Society of Gynecologic Oncology.
Specific BRCA mutations confer higher risks of breast cancer, while other BRCA mutations confer higher risks of ovarian cancer.
Experimental vaccine and cancer drug each slow disease progression in ovarian cancer, researchers find.
A recent study examined the accuracy of the bimanual pelvic examination in identifying ovarian cancer.
Ovarian Cancer Clinical Trials
- Genetic Testing for Hereditary Cancer Syndromes (Fact Sheet)
- Sweeping prostate cancer review upends widely held belief on radiation after surgery
- Statin use inversely linked to risk of pancreatic cancer
- Survival longer in patients with early stage non-small cell lung cancer (NSCLC) with low tumor metabolic activity
- Promising drug offers new paradigm for treating leukemia
- Multidisciplinary Bone Marrow Program Prepares RNs to Perform Aspirations, Biopsies
- Model Details Challenges of Educating Staff to Care for Both Pediatric and Adult Oncology Patients
- Oncology-Specific, One-Day Orientation Program Encourages Multidisciplinary Collaboration
- Educational Walk Through A Colon Promotes Colorectal Cancer Screening
- Gastrointestinal Oncology Nurse Navigation Improves Patient Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|